US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...
Learn the common causes of tongue swelling, effective treatments, and warning signs that require immediate medical attention ...
The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback